| Improving the prediction of cardiac surgery–associated acute kidney injury J Crosina, J Lerner, J Ho, N Tangri, P Komenda, B Hiebert, N Choi, ... Kidney international reports 2 (2), 172-179, 2017 | 25 | 2017 |
| Congenital absence of nitric oxide synthase 3 potentiates cardiac dysfunction and reduces survival in doxorubicin-and trastuzumab-mediated cardiomyopathy M Zeglinski, S Premecz, J Lerner, P Wtorek, D Hasanally, R Chaudhary, ... Canadian Journal of Cardiology 30 (3), 359-367, 2014 | 22 | 2014 |
| Integrating risk-based care for patients with chronic kidney disease in the community: study protocol for a cluster randomized trial O Harasemiw, N Drummond, A Singer, A Bello, P Komenda, C Rigatto, ... Canadian journal of kidney health and disease 6, 2054358119841611, 2019 | 20 | 2019 |
| Wanting family medicine without primary care J Lerner Canadian Family Physician 64 (2), 155-156, 2018 | 16 | 2018 |
| Multimodality imaging of anomalous pulmonary veins R Nepomuceno, M Zeglinski, J Lerner, W Czarnecki, IDC Kirkpatrick, ... Cardiovascular Ultrasound 9, 1-3, 2011 | 7 | 2011 |
| Vouloir la médecine familiale sans les soins primaires J Lerner Canadian Family Physician 64 (2), e104-e105, 2018 | 1 | 2018 |
| RE: Treatment of secondary syphilis J Lerner | | 2024 |
| RE: Time off work J Lerner | | 2023 |
| RE: Recommended serological test follow-up after treatment J Lerner | | 2023 |
| Time off work J Lerner Canadian Family Physician 63 (8), 596-596, 2017 | | 2017 |
| The Effects of Steroid Hormones on Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase (LCHAD) Enzyme Expression in LCHAD Deficient Cells and Induction of Long-Chain Fatty Acid Binding … GY Minuk, G Pollock, J Lezen, V Perez-Alvarez, F Burczynski, J Uhanova Journal of Gastroenterology and Hepatology Research 4 (9), 1768-1771, 2015 | | 2015 |
| HCV protein‐induced cytokine predicts treatment outcomes in chronic hepatitis C virus infection C Krueger, M Collister, GY Minuk, A Janke, J Lerner, SGM Wong, ... Liver International 34 (6), e62-e70, 2014 | | 2014 |
| Disruption of Nitric Oxide Synthase 3 Potentiates Cardiac Dysfunction and Reduces Survival in Doxorubucin and Trastuzumab Mediated Cardiomyopathy M Zeglinski, S Bohonis, J Lerner, M DaSilva, A Sharma, J Thliveris, ... Circulation 124 (suppl_21), A10301-A10301, 2011 | | 2011 |
| Abstracts of the Plenary and Symposia Talks; and Poster Presentations M Abdellatif, D Sayed, D Baetz, J Gordon, H Gang, L Kirshenbaum, ... Experimental and Clinical Cardiology 16 (Suppl A), 1A-34A, 2011 | | 2011 |
| 727 Congenital absence of NOS3 potentiates left ventricular dysfunction and increases mortality in doxorubicin and trastuzumab mediated cardiomyopathy M Zeglinski, S Bohonis, J Lerner, A Sharma, J Thliveris, PK Singal, ... Canadian Journal of Cardiology 27 (5), S329-S330, 2011 | | 2011 |
